Nada Lallous

1.5k total citations
40 papers, 959 citations indexed

About

Nada Lallous is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Nada Lallous has authored 40 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Pulmonary and Respiratory Medicine and 14 papers in Genetics. Recurrent topics in Nada Lallous's work include Prostate Cancer Treatment and Research (20 papers), Estrogen and related hormone effects (14 papers) and Hormonal and reproductive studies (8 papers). Nada Lallous is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Estrogen and related hormone effects (14 papers) and Hormonal and reproductive studies (8 papers). Nada Lallous collaborates with scholars based in Canada, France and United States. Nada Lallous's co-authors include Artem Cherkasov, Paul S. Rennie, Eric Leblanc, Martin Gleave, Kush Dalal, Kriti Singh, Santiago Ramón‐Maiques, Fuqiang Ban, Joseph Lee and A. Grande-García and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Nada Lallous

38 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nada Lallous Canada 19 558 473 212 203 149 40 959
Kriti Singh Canada 13 323 0.6× 371 0.8× 145 0.7× 245 1.2× 143 1.0× 38 695
Eric Leblanc Canada 21 684 1.2× 679 1.4× 192 0.9× 433 2.1× 307 2.1× 38 1.4k
Masuo Yamaoka Japan 17 351 0.6× 651 1.4× 192 0.9× 296 1.5× 413 2.8× 24 1.0k
Venkatesh Handratta United States 12 435 0.8× 364 0.8× 151 0.7× 412 2.0× 180 1.2× 14 930
S. Elaine Barrie United Kingdom 16 564 1.0× 564 1.2× 216 1.0× 265 1.3× 362 2.4× 25 1.3k
Carmen A. Bañuelos Canada 17 867 1.6× 927 2.0× 352 1.7× 321 1.6× 331 2.2× 30 1.5k
Takahito Hara Japan 24 757 1.4× 819 1.7× 430 2.0× 347 1.7× 456 3.1× 51 1.7k
Mark Salvati United States 15 399 0.7× 403 0.9× 71 0.3× 357 1.8× 359 2.4× 48 1.0k
M-H. Tan Singapore 3 338 0.6× 317 0.7× 113 0.5× 172 0.8× 132 0.9× 6 703
Luciana F. Macedo United States 19 443 0.8× 198 0.4× 254 1.2× 579 2.9× 99 0.7× 26 1.0k

Countries citing papers authored by Nada Lallous

Since Specialization
Citations

This map shows the geographic impact of Nada Lallous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada Lallous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada Lallous more than expected).

Fields of papers citing papers by Nada Lallous

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nada Lallous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada Lallous. The network helps show where Nada Lallous may publish in the future.

Co-authorship network of co-authors of Nada Lallous

This figure shows the co-authorship network connecting the top 25 collaborators of Nada Lallous. A scholar is included among the top collaborators of Nada Lallous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nada Lallous. Nada Lallous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pandey, Mohit, Jane Foo, Morgan A. Alford, et al.. (2025). A scalable reinforcement learning approach for screening large peptide libraries for bioactive peptide discovery. Nature Communications. 16(1). 11685–11685.
2.
Chamberlain, Thomas C., et al.. (2025). The regulation of miR-155 strand selection by CELF2, FUBP1 and KSRP proteins. Scientific Reports. 15(1). 30217–30217.
3.
Zhai, Beibei, Fariba Ghaidi, Michael M. Lizardo, et al.. (2023). A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma. Clinical Cancer Research. 29(17). 3541–3553. 19 indexed citations
4.
Pandey, Mohit, et al.. (2023). PurificationDB: database of purification conditions for proteins. Database. 2023. 1 indexed citations
5.
Morin, Hélène, Mohit Pandey, Fuqiang Ban, et al.. (2023). Novel Inhibitors of androgen receptor's DNA binding domain identified using an ultra‐large virtual screening. Molecular Informatics. 42(8-9). e2300026–e2300026. 7 indexed citations
6.
Lallous, Nada, C. Antonio Sánchez, Bei Sun, et al.. (2021). Evaluation of Darolutamide (ODM201) Efficiency on Androgen Receptor Mutants Reported to Date in Prostate Cancer Patients. Cancers. 13(12). 2939–2939. 19 indexed citations
7.
Song, Yi, Ahn R. Lee, Joseph Lee, et al.. (2021). Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics. Frontiers in Oncology. 10. 633142–633142. 41 indexed citations
8.
Morova, Tunç, Daniel R. McNeill, Nada Lallous, et al.. (2020). Androgen receptor-binding sites are highly mutated in prostate cancer. Nature Communications. 11(1). 832–832. 36 indexed citations
9.
Lallous, Nada, et al.. (2019). Androgen receptor plasticity and its implications for prostate cancer therapy. Cancer Treatment Reviews. 81. 101871–101871. 40 indexed citations
10.
Lallous, Nada, Eric Leblanc, Fuqiang Ban, et al.. (2018). Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer. European Journal of Medicinal Chemistry. 160. 108–119. 38 indexed citations
11.
Singh, Kriti, Nada Lallous, Kush Dalal, et al.. (2018). Benzothiophenone Derivatives Targeting Mutant Forms of Estrogen Receptor-α in Hormone-Resistant Breast Cancers. International Journal of Molecular Sciences. 19(2). 579–579. 10 indexed citations
12.
Dalal, Kush, Meixia Che, Aishwariya Sharma, et al.. (2017). Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor–Chromatin Interactions. Molecular Cancer Therapeutics. 16(10). 2281–2291. 27 indexed citations
13.
14.
Lallous, Nada, Stanislav Volik, Shannon Awrey, et al.. (2016). Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients. Genome biology. 17(1). 10–10. 154 indexed citations
15.
Hassona, Mohamed D.H., Eric Leblanc, Kate Frewin, et al.. (2014). Identification of a Potent Antiandrogen that Targets the BF3 Site of the Androgen Receptor and Inhibits Enzalutamide-Resistant Prostate Cancer. Chemistry & Biology. 21(11). 1476–1485. 59 indexed citations
16.
Grande-García, A., et al.. (2013). Structure, Functional Characterization, and Evolution of the Dihydroorotase Domain of Human CAD. Structure. 22(2). 185–198. 49 indexed citations
17.
Lallous, Nada, et al.. (2013). Expression, purification, crystallization and preliminary X-ray diffraction analysis of the aspartate transcarbamoylase domain of human CAD. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 69(12). 1425–1430. 10 indexed citations
18.
Lallous, Nada, A. Grande-García, Rafael Molina, & Santiago Ramón‐Maiques. (2012). Expression, purification, crystallization and preliminary X-ray diffraction analysis of the dihydroorotase domain of human CAD. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 68(11). 1341–1345. 12 indexed citations
19.
Lallous, Nada, Pierre Legrand, Alastair G. McEwen, et al.. (2011). The PHD Finger of Human UHRF1 Reveals a New Subgroup of Unmethylated Histone H3 Tail Readers. PLoS ONE. 6(11). e27599–e27599. 31 indexed citations
20.
Delagoutte, B., Nada Lallous, Catherine Birck, P Oudet, & Jean‐Pierre Samama. (2008). Expression, purification, crystallization and preliminary crystallographic study of the SRA domain of the human UHRF1 protein. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 64(10). 922–925. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kriti Singh Breakdown of academic impact, for papers by Eric Leblanc Breakdown of academic impact, for papers by Masuo Yamaoka Breakdown of academic impact, for papers by Venkatesh Handratta Breakdown of academic impact, for papers by S. Elaine Barrie Breakdown of academic impact, for papers by Carmen A. Bañuelos Breakdown of academic impact, for papers by Takahito Hara Breakdown of academic impact, for papers by Mark Salvati Breakdown of academic impact, for papers by M-H. Tan Breakdown of academic impact, for papers by Luciana F. Macedo
Rankless by CCL
2026